Nasal Drug Delivery Market
Nasal Drug Delivery Market Size, Share & Trends Analysis Report by Dosage Form (Gels, Sprays, Drops and Liquids, and Others), by Containers (Non-Pressurized Containers, and Pressurized Containers) by Therapeutic Application (Rhinitis, Nasal Congestion, Asthma, and Others) and by End-User (Hospitals, and Home Health Care) Forecast Period (2024-2031)
Nasal drug delivery market is anticipated to grow at a CAGR of 7.8% during the forecast period (2024-2031). Nasal drug delivery is gaining popularity owing to its various advantages such as rapid onset of action, easy administration, and avoidance of first-pass metabolism. This method has been particularly highlighted during the COVID-19 pandemic for its potential to deliver vaccines and respiratory treatments. Ongoing research and development efforts are focused on improving delivery efficiency and addressing unmet medical needs in this field.
Market Dynamics
Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases, particularly respiratory conditions such as asthma and central nervous system disorders, necessitates the development of effective nasal drug delivery systems. According to the National Center for Chronic Disease Prevention and Health Promotion, in February 2024, an estimated 129 million individuals in the US are living with at least one major chronic disease, as defined by the US Department of Health and Human Services. Notably, five out of the top 10 leading causes of mortality in the US are either preventable or closely linked to treatable chronic diseases. The prevalence of chronic diseases has steadily increased over the past two decades, and this upward trend is expected to persist.
Rising Incidence of Diabetes
The rising diabetes incidence necessitates regular medication management, and nasal drug delivery offers a convenient alternative for administering insulin and other diabetes-related medications, particularly for patients with injection difficulties. According to the US government, in May 2024, the prevalence of diabetes in the US was estimated to be 11.6% of the population, with a total of 38.4 million individuals affected. Out of these, 29.7 million Individuals were diagnosed, while 8.7 million individuals had undiagnosed diabetes. Among adults, the prevalence of diabetes was 14.7%, with 22.8% of those affected being undiagnosed.
Technological Advancements in Drug Delivery
The development of metered-dose nasal sprays, in addition to advanced formulations such as nanoparticles and microspheres, has allowed for more precise dosing, increased treatment efficacy, and enhanced patient adherence to treatment regimens. These technological advancements in drug delivery have been instrumental in improving drug absorption and targeting capabilities. For instance, in July 2023, Viatris and Kindeva Drug Delivery launched Breyna, the first generic version of AstraZeneca's Symbicort, approved by the FDA. The drug-device combination product is indicated for asthma and COPD patients, available in 80mcg/4.5mcg and 160mcg/4.5mcg dosage strengths.
Market Segmentation
- Based on dosage form, the market is segmented into gels, sprays, drops and liquids, and others (powders).
- Based on containers, the market is segmented into non-pressurized containers and pressurized containers.
- Based on therapeutic application, the market is segmented into rhinitis, nasal congestion, asthma, and others (vaccination).
- Based on the end-user, the market is segmented into hospitals and home health care.
Rhinitis Holds a Considerable Market Share
The ongoing R&D activities are centered on enhancing nasal drug delivery systems and exploring new therapeutic areas. For instance, Glenmark launched Ryaltris-AZ Nasal Spray in India for treating moderate to severe allergic rhinitis. The spray, containing Mometasone furoate 50 mcg and Azelastine 140 mcg, relieves symptoms such as stuffy nose, runny nose, nasal itching, sneezing, and itchy, red, and watery eyes.
Regional Outlook
The global nasal drug delivery market is further segmented based on geography including Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), North America (the US, and Canada), and the Rest of the World (the Middle East & Africa, and Latin America).
Global Nasal Drug Delivery Market Growth by Region 2024-2031
Asia-Pacific to Exhibit Considerable Market Growth
The Asia-Pacific region is anticipated to experience substantial growth in the nasal drug delivery market due to demographic shifts and the expansion of healthcare infrastructure. According to the India Ageing Report, in 2023, the number of older individuals is expected to double to 2.1 billion by 2050, accounting for 22.9% of the total population. This increase is visible across all regions, with more developed areas seeing a 26.0% increase and less developed regions seeing a 20.0% increase. Asia, home to 58.0% of the global older persons population, is expected to have 1.3 billion older persons by 2050, constituting 25.0% of the total population. India is also expected to experience a similar increase, with 149 million aged 60 years or above in 2022.
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the global nasal drug delivery market include Aptargroup, Inc., Becton, Dickinson, and Co. Novartis AG, Pfizer Inc., and Johnson & Johnson Services, Inc. among others. The market players are focusing on capitalizing on growth by adopting strategies such as collaboration, partnerships, and market expansion among others. For instance, in February 2023 Aptar Pharma introduced APF Futurity, its first metal-free, multidose nasal spray pump, designed for recyclability. It has achieved a Class AA certification from cyclos-HTP for Europe's recycling streams, minimizing separation efforts and promoting higher quality recyclates.
The Report Covers
- Market value data analysis of 2023 and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global nasal drug delivery market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Industry Trends
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Aptargroup, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Novartis AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Pfizer Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Nasal Drug Delivery Market by Dosage Form
4.1.1. Gels
4.1.2. Sprays
4.1.3. Drops and Liquids
4.1.4. Other (Powders)
4.2. Global Nasal Drug Delivery Market by Containers
4.2.1. Non-Pressurized Containers
4.2.2. Pressurized Containers
4.3. Global Nasal Drug Delivery Market by Therapeutic Application
4.3.1. Rhinitis
4.3.2. Nasal Congestion
4.3.3. Asthma
4.3.4. Others (Vaccination)
4.4. Global Nasal Drug Delivery Market by End-User
4.4.1. Hospitals
4.4.2. Home Healthcare
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East and Africa
6. Company Profiles
6.1. Bayer AG
6.2. Becton, Dickinson, and Co.
6.3. DTR Medical Ltd
6.4. F. Hoffmann-La Roche Ltd
6.5. Glenmark Pharmaceuticals Ltd.
6.6. Herantis Pharma Plc
6.7. Hikma Pharmaceuticals PLC
6.8. ICON plc
6.9. Johnson & Johnson Services, Inc.
6.10. Nanoform Finland Oyj
6.11. NEMERA Group
6.12. Neurelis, Inc.
6.13. Olympus Corp.
6.14. Premier Inc.
6.15. Presspart Verwaltungs-GmbH
6.16. Procter & Gamble
6.17. Sanofi SA
6.18. Sumitomo Pharma America, Inc.
6.19. Summit Medical LLC.
6.20. Teleflex Inc.
6.21. Teva Pharmaceutical Industries Ltd.
6.22. Vectura Fertin Pharma Inc.
6.23. Viatris Inc.
1. Global Nasal Drug Delivery Market Research And Analysis By Dosage Form, 2023-2031 ($ Million)
2. Global Gels Nasal Drug Delivery Market Research And Analysis By Region, 2023-2031 ($ Million)
3. Global Sprays Nasal Drug Delivery Market Research And Analysis By Region, 2023-2031 ($ Million)
4. Global Drops and Liquids Nasal Drug Delivery Market Research And Analysis By Region, 2023-2031 ($ Million)
5. Global Others Dosage Form Nasal Drug Delivery Market Research And Analysis By Region, 2023-2031 ($ Million)
6. Global Nasal Drug Delivery Market Research And Analysis By Containers, 2023-2031 ($ Million)
7. Global Nasal Drug Delivery By Non-Pressurized Containers Market Research And Analysis By Region, 2023-2031 ($ Million)
8. Global Nasal Drug Delivery By Pressurized Containers Market Research And Analysis By Region, 2023-2031 ($ Million)
9. Global Nasal Drug Delivery Market Research And Analysis By Therapeutic Application, 2023-2031 ($ Million)
10. Global Nasal Drug Delivery In Rhinitis Market Research And Analysis By Region, 2023-2031 ($ Million)
11. Global Nasal Drug Delivery In Nasal Congestion Market Research And Analysis By Region, 2023-2031 ($ Million)
12. Global Nasal Drug Delivery In Asthma Market Research And Analysis By Region, 2023-2031 ($ Million)
13. Global Nasal Drug Delivery In Other Therapeutic Application Market Research And Analysis By Region, 2023-2031 ($ Million)
14. Global Nasal Drug Delivery Market Research And Analysis By End-User, 2023-2031 ($ Million)
15. Global Nasal Drug Delivery For Hospitals Market Research And Analysis By Region, 2023-2031 ($ Million)
16. Global Nasal Drug Delivery For Home Health Care Market Research And Analysis By Region, 2023-2031 ($ Million)
17. Global Nasal Drug Delivery Market Research And Analysis By Region, 2023-2031 ($ Million)
18. North American Nasal Drug Delivery Market Research And Analysis By Country, 2023-2031 ($ Million)
19. North American Nasal Drug Delivery Market Research And Analysis By Dosage Form, 2023-2031 ($ Million)
20. North American Nasal Drug Delivery Market Research And Analysis By Containers, 2023-2031 ($ Million)
21. North American Nasal Drug Delivery Market Research And Analysis By End-User, 2023-2031 ($ Million)
22. European Nasal Drug Delivery Market Research And Analysis By Country, 2023-2031 ($ Million)
23. European Nasal Drug Delivery Market Research And Analysis By Dosage Form, 2023-2031 ($ Million)
24. European Nasal Drug Delivery Market Research And Analysis By Containers, 2023-2031 ($ Million)
25. European Nasal Drug Delivery Market Research And Analysis By End-User, 2023-2031 ($ Million)
26. Asia-Pacific Nasal Drug Delivery Market Research And Analysis By Country, 2023-2031 ($ Million)
27. Asia-Pacific Nasal Drug Delivery Market Research And Analysis By Dosage Form, 2023-2031 ($ Million)
28. Asia-Pacific Nasal Drug Delivery Market Research And Analysis By Containers, 2023-2031 ($ Million)
29. Asia-Pacific Nasal Drug Delivery Market Research And Analysis By End-User, 2023-2031 ($ Million)
30. Rest Of The World Nasal Drug Delivery Market Research And Analysis By Region, 2023-2031 ($ Million)
31. Rest Of The World Nasal Drug Delivery Market Research And Analysis By Dosage Form, 2023-2031 ($ Million)
32. Rest Of The World Nasal Drug Delivery Market Research And Analysis By Containers, 2023-2031 ($ Million)
33. Rest Of The World Nasal Drug Delivery Market Research And Analysis By End-User, 2023-2031 ($ Million)
1. Global Nasal Drug Delivery Market Share By Dosage Form, 2023 Vs 2031 (%)
2. Global Gels Nasal Drug Delivery Market Share By Region, 2023 Vs 2031 (%)
3. Global Sprays Nasal Drug Delivery Market Share By Region, 2023 Vs 2031 (%)
4. Global Drops and Liquids Nasal Drug Delivery Market Share By Region, 2023 Vs 2031 (%)
5. Global Others Dosage Form Nasal Drug Delivery Market Share By Region, 2023 Vs 2031 (%)
6. Global Nasal Drug Delivery Market Share By Containers, 2023 Vs 2031 (%)
7. Global Nasal Drug Delivery By Non-Pressurized Containers Market Share By Region, 2023 Vs 2031 (%)
8. Global Nasal Drug Delivery By Pressurized Containers Treatment Market Share By Region, 2023 Vs 2031 (%)
9. Global Nasal Drug Delivery Market Share By Therapeutic Application, 2023 Vs 2031 (%)
10. Global Nasal Drug Delivery In Rhinitis Market Share By Region, 2023 Vs 2031 (%)
11. Global Nasal Drug Delivery In Nasal Congestion Market Share By Region, 2023 Vs 2031 (%)
12. Global Nasal Drug Delivery In Asthma Market Share By Region, 2023 Vs 2031 (%)
13. Global Nasal Drug Delivery In Others Therapeutic Application Market Share By Region, 2023 Vs 2031 (%)
14. Global Nasal Drug Delivery Market Share By End-User, 2023 Vs 2031 (%)
15. Global Nasal Drug Delivery For Hospitals Market Share By Region, 2023 Vs 2031 (%)
16. Global Nasal Drug Delivery For Home Health Care Market Share By Region, 2023 Vs 2031 (%)
17. Global Nasal Drug Delivery Market Share By Region, 2023 Vs 2031 (%)
18. Us Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
19. Canada Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
20. UK Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
21. France Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
22. Germany Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
23. Italy Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
24. Spain Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
25. Rest Of Europe Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
26. India Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
27. China Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
28. Japan Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
29. South Korea Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
30. Rest Of Asia-Pacific Nasal Drug Delivery Market Size, 2023-2031 ($ Million)
